Related Experiment Video
Updated: May 24, 2026
04:59
Disposable Dosators Intended for Dry Powder Delivery to Mice
Published on: August 18, 2023
Dosing rationale for fixed-dose combinations in children: shooting from the hip?
M Cella1, F Kloprogge, M Danhof
1Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden University, Leiden, The Netherlands.
Clinical Pharmacology and Therapeutics
|March 9, 2012
Summary
Model-based approaches are crucial for selecting pediatric drug combination doses. Flexible dosing ratios, not fixed ones, are needed to ensure comparable drug exposure across different age groups.
Area of Science:
- Pharmacokinetics and Drug Development
- Pediatric Pharmacology
- Computational Modeling in Medicine
Background:
- Optimizing drug combination dosing in pediatric populations presents unique challenges.
- Bridging studies aim to extrapolate adult drug data to children, but require careful consideration of age-specific factors.
- Fixed-dose combinations may not achieve equivalent therapeutic exposure across diverse pediatric age groups.
Purpose of the Study:
- To evaluate a model-based approach for pharmacokinetic (PK) bridging and dose selection of drug combinations in children.
- To illustrate the necessity of flexible dosing strategies for pediatric drug combinations.
- To demonstrate the impact of covariate interactions on drug PK in pediatric populations.
Main Methods:
- Developed population PK models for atovaquone (ATV) and proguanil (PGN) using adult and pediatric plasma concentration data.
- Utilized PK parameter estimates to simulate drug exposure in pediatric patients under various dosing scenarios.
- Analyzed the influence of body weight (BW) and ethnicity as covariates on drug PK.
Main Results:
- Simulations revealed that different dose ratios of ATV and PGN may be required across pediatric age groups to match adult exposure levels.
- Covariate interactions, particularly body weight and ethnicity, significantly impact drug PK in children.
- A model-based approach demonstrated the potential for achieving comparable target exposure levels through flexible dosing.
Conclusions:
- Model-based pharmacokinetic analysis is critical for rational dose selection of drug combinations in pediatric populations.
- Flexible rather than fixed-dose ratios are often necessary to ensure comparable target drug exposure in pediatric bridging studies.
- This approach supports the safe and effective use of drug combinations in children by accounting for individual variability.
Related Concept Videos
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...